{"id":"tp-50478","type":"article-newspaper","title":"Santen Pharmaceutical First-Half Revenue Rises 3.9% to ¥143.289 Billion","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/50478","datePublished":"2026-11-07T01:22:31.000Z","dateModified":"2026-11-07T01:22:31.000Z","language":"en","abstract":"Basic earnings per share was ¥48.05 for the six months ended Sept. 30, 2026. Santen kept its fiscal 2027 revenue and operating profit forecasts unchanged.","section":"Business","references":[]}